Jan 28 (Reuters) - Milestone Pharmaceuticals Inc MIST.O:
MILESTONE PHARMACEUTICALS PROVIDES 2025 CORPORATE OUTLOOK AND WILL HOST INVESTOR EVENT ON FEBRUARY 25 IN NYC
MILESTONE PHARMACEUTICALS INC: PDUFA DATE OF MARCH 27, 2025 FOR CARDAMYST™ (ETRIPAMIL) NASAL SPRAY
MILESTONE PHARMACEUTICALS INC: PLANS TO INITIATE PHASE 3 STUDY IN AFIB-RVR IN H1 2025
Source text: ID:nGNX52zbjR
Further company coverage: MIST.O
(((( Reuters.briefs@thomsonreuters.com ;));))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.